MitchellBensonMD

PubMed

• 331 citations
  Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
  Josep Domingo-Domenech, Samuel J. Vidal, Veronica Rodriguez-Bravo, Mireia Castillo-Martin, S. Aidan Quinn
  Cancer Cell. 2012-09-11
• 252 citations
  Single luminal epithelial progenitors can generate prostate organoids in culture
  Chee Wai Chua, Maho Shibata, Ming Lei, Roxanne Toivanen, LaMont J. Barlow
  Nature Cell Biology. 2014-10-01
• 489 citations
  Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
  Suk Hyung Lee, Wenhuo Hu, Justin T. Matulay, Mark V. Silva, Tomasz Owczarek
  Cell. 2018-04-05

Journal Articles

• SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer who had Recurrence after at Least 2 Prior Courses of Intraves...  
  Skinner EC, Goldman B, Sakr WA, Petrylak DP, Lenz HJ, Lee CT, Wilson SS, Benson M, Lerner SP, Tangen CM, Thompson IM, J Urol, 1/15/2013
• Pathological Outcome and Biochemical Recurrence-free Survival after Radical Prostatectomy in African-American, Afro-Caribbean (Jamaican) And Caucasian-American Men: An...  
  Ritch CR, Morrison BF, Hruby G, Coard KC, Mayhew R, Aiken W, Benson MC, McKiernan JM, BJU Int, 1/1/2013
• Long-term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin Therapy  
  Barlow LJ, McKiernan JM, Benson MC, J Urol, 1/1/2013
• Dysregulation of Circulating MicroRNAs and Prediction of Aggressive Prostate Cancer  
  Shen J, Hruby GW, McKiernan JM, Gurvich I, Lipsky MJ, Benson MC, Santella RM, Prostate, 1/15/2012
• A Comparison of the Outcomes of Neoadjuvant and Adjuvant Chemotherapy for Clinical T2-T4aN0-N2M0 Bladder Cancer  
  Wosnitzer MS, Hruby GW, Murphy AM, Barlow LJ, Cordon-Cardo C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM, Cancer, 1/1/2012
• Relative Efficacy of Perioperative Gemcitabine and Cisplatin versus Methotrexate, Vinblastine, Adriamycin, and Cisplatin in the Management of Locally Advanced Urotheli...  
  Yeshchina O, Badalato GM, Wosnitzer MS, Hruby G, RoyChoudhury A, Benson MC, Petrylak DP, McKiernan JM, Urology, 1/1/2012
• Effect of Delaying Surgery on Radical Prostatectomy Outcomes: A Contemporary Analysis  
  Korets R, Seager CM, Pitman MS, Hruby GW, Benson MC, McKiernan JM, BJU Int, 1/1/2012
• Routine Transition Zone Biopsy During Active Surveillance for Prostate Cancer Rarely Provides Unique Evidence of Disease Progression  
  Richard JL, Motamedinia P, McKiernan JM, Decastro GJ, Benson MC, J Urol, 1/1/2012
• Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-dependent Tumor-initiating Cells  
  Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal DM, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, Petr..., Cancer Cell, 1/1/2012
•  
  Shapiro EY, Lipsky MJ, Cha DY, McKiernan JM, Benson MC, Gupta M, J Endourol, 1/1/2012
• The First Assistant Sparing Technique Robot-assisted Partial Nephrectomy Decreases Warm Ischemia Time While Maintaining Good Perioperative Outcomes  
  Berg WT, Rich CR, Badalato GM, Deibert CM, Wambi CO, Landman J, Benson MC, Badani KK, J Endourol, 1/1/2012
• Immediate Radical Cystectomy vs Conservative Management for High Grade CT1 Bladder Cancer: Is There a Survival Difference?  
  Badalato GM, Gaya JM, Hruby G, Patel T, Kates M, Sadeghi N, Benson MC, McKiernan JM, BJU Int, 1/1/2012
• Role of Immediate Confirmatory Prostate Biopsy to Ensure Accurate Eligibility for Active Surveillance  
  Motamedinia P, Richard JL, McKiernan JM, DeCastro GJ, Benson MC, Urology, 1/1/2012
• DNA Methylation Changes Correlate with Gleason Score and Tumor Stage in Prostate Cancer  
  Delgado-Cruzata, L., Hruby, G. W., Gonzalez, K., McKiernan, J., Benson, M. C., Santella, R. M., Shen, J, DNA and Cell Biology, 1/1/2012
• Validating the Use of the Mimic DV-trainer for Robotic Surgery Skill Acquisition among Urology Residents  
  Korets R, Mues AC, Graversen JA, Gupta M, Benson MC, Cooper KL, Landman J, Badani KK, Urology, 1/1/2011
• Predictive Value of Microtubule Associated Proteins Tau and Stathmin in Patients with Nonmuscle Invasive Bladder Cancer Receiving Adjuvant Intravesical Taxane Therapy  
  Wosnitzer MS, Domingo-Domenech J, Castillo-Martin M, Ritch C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM, Cordon-Cardo C, J Urol, 1/1/2011
• Impact of HMG-CoA Reductase Inhibitor (Statin) Use on Blood Loss during Robot-assisted and Open Radical Prostatectomy  
  Truesdale MD, Polland AR, Graversen JA, Sartori S, Hruby GW, Landman J, McKiernan JM, Benson MC, Badani KK, J Endourol, 1/1/2011
• Comparison of Distal Ureteral Management Strategies during Laparoscopic Nephroureterectomy  
  Ritch CR, Kearns JT, Mues AC, Hruby GW, Benson MC, McKiernan JM, Landman J, J Endourol, 1/1/2011
• A Phase I Trial of Intravesical Nanoparticle Albumin-bound Paclitaxel in the Treatment of Bacillus Calmette-Guérin Refractory Nonmuscle Invasive Bladder Cancer  
  McKiernan JM, Barlow LJ, Laudano MA, Mann MJ, Petrylak DP, Benson MC, J Urol, 1/1/2011
• Effect of Statin Use on Biochemical Outcome following Radical Prostatectomy  
  Ritch CR, Hruby G, Badani KK, Benson MC, McKiernan JM, BJU Int, 1/1/2011
• Heparin Prophylaxis and the Risk of Venous Thromboembolism after Robotic-assisted Laparoscopic Prostatectomy  
  Patel T, Kirby W, Hruby G, Benson MC, McKiernan JM, Badani K, BJU Int, 1/1/2011
• Natural History of Renal Cortical Neoplasms during Active Surveillance with Follow-up Longer than 5 Years  
  Haramis G, Mues AC, Rosales JC, Okhunov Z, Lanzac AP, Badani K, Gupta M, Benson MC, McKiernan J, Landman J, Urology, 1/1/2011
• The Interaction of Body Mass Index and Race in Predicting Biochemical Failure after Radical Prostatectomy  
  Lee DJ, Ritch C, Desai M, Benson MC, McKiernan JM, BJU Int, 1/1/2011
• Gleason Score Concordance on Biopsy-confirmed Prostate Cancer: Is Pathological Re-evaluation Necessary prior to Radical Prostatectomy?  
  Truesdale MD, Cheetham PJ, Turk AT, Sartori S, Hruby GW, Dinneen EP, Benson MC, Badani KK, BJU Int, 1/1/2011
• Renal Function and Oncologic Outcomes in Nephron Sparing Surgery for Renal Masses in Solitary Kidneys  
  Lee DJ, Hruby G, Benson MC, McKiernan JM, World J Urol, 1/1/2011
• Join now to see all

Books/Book Chapters

• Campbell-Walsh Urology 
  Chapter: Cutaneous Continent Urinary Diversion, Surgical Video 
  Benson, M.CEditors: Wein, A.J., Kavoussi, L.R., Novick, A.C., Partin, A.W., and Peters, C.A..Elsevier Saunders2012
• Campbell-Walsh Urology 
  Chapter: Cutaneous Continent Urinary Diversion 
  Page 2450 - 2478McKiernan, J.M., DeCastro, G.J., and Benson, M.C.Editors: Wein, A.J., Kavoussi, L.R., Novick, A.C., Partin, A.W., and Peters, C.A.Elsevier Saunders2012
• Campbell's Urology 
  Chapter: Cutaneous Continent Urinary Diversion 
  Page 2579 - 2612Benson, M.C., McKiernan, J.M., and Olsson, C.A.Editors: Walsh, P.C., Retik, A.B., and Vaughan, E.D..W.B. Saunders2007
• Prostate Specific Antigen 
  Chapter: PSA Density: Does It Still Have Utility? 
  Knowles, D., Bagiella, E., Benson, M.CEditors: Brawer, M.K..Decker, New York2001
• Objectives for Urology Residency Education 
  Chapter: Continent Urinary Diversion 
  Benson, MEditors: Wein, A..2000
• Columbia Presbyterian Medical Center - Second Opinions 
  Chapter: Prostate Surgery 
  Page 248 - 255Benson, M.CEditors: Rose, E.St. Martin’s Press, New York2000
• Urology for Primary Care Physicians 
  Chapter: Prostate Specific Antigen 
  Page 273 - 284Stifelman, M. and Benson, M.CEditors: Nseyo, U.O., Weinman, E. and Lamm, D.L..W.B. Saunders, Comp. Philadelphia1999
• Atlas of Urologic Surgery 
  Chapter: Sigmoidocystoplasty 
  Page 735 - 740Benson, M.CEditors: Hinman, F., Jr..W. B. Saunders, Philadelphia1998
• Atlas of Surgical Techniques in Urology 
  Chapter: Psoas Hitch and Boari Flap 
  Page 379 - 383Benson, M.CEditors: Whitehead, E.D.J.B. Lippincott-Raven Company, Philadelphia1997
• Renal and Urologic Aspects of HIV Infection 
  Chapter: Urologic Manifestations of HIV Infection 
  Page 181 - 194Kennedy, W., Benson, M.C. and Kaplan, S.AEditors: Kimmel, P.L. and Berns, J.S.Kimmel, P.L. and Berns, J.S, New York1995
• Reoperative Urology 
  Chapter: Complications of Continent Urinary Diversion 
  Page 287 - 296Katz, A.E., Benson, M.C. and Olsson, C.A.Editors: Cohen, M.S. and Resnick, M.I.Little Brown and Company, Boston1995
• Clinical Urology 
  Chapter: Pheochromocytoma 
  Page 230 - 235Whang, I.S., Walton, G. and Benson, M.CEditors: Krane, R.J., Siroky, M.B. and Fitzpatrick, J.M.J.B. Lippincott, Philadelphia1994
• Clinical Uro-oncology and the New Biology 
  Chapter: New Techniques in Management and Treatment of Superficial Bladder Cancer 
  Page 65 - 78Franklin, J. and Benson, M.CEditors: Neal, D.E.Springer-Verlag, London1994
• Current Urologic Therapy #3 
  Chapter: Systemic Chemotherapy in Metastatic Bladder Cancer 
  Page 349 - 352Benson, M.CEditors: Seidmon, E.J., Hanno, P.M. and Kaufman, J.J..W.B. Saunders Company, Philadelphia1993
• Objectives for Urology Residency Education 
  Chapter: Molecular Biology and Genetic Aspects of Urologic Disease 
  Benson, M.CEditors: Resnick, M.I..Society of University Urologists1993
• Prostate Cancer 
  Chapter: Cytometry and Cytopathology of the Prostate: The Current Concepts 
  Page 59 - 73Benson, M.CEditors: Crawford E.D. and Das, S.Marcel Dekker, Inc1993
• Current Therapy in Oncology 
  Chapter: Adenocarcinoma of the Prostate 
  Page 468 - 473Olsson, C.A., Sawczuk, I.S. and Benson, M.C.Editors: Niederhuber, J.E.B.C. Decker - Mosby Year Book, St. Louis1992
• Gynecologic and Obstetric Urology 
  Chapter: Continent Urinary Diversion 
  Page 211 - 240Benson, M.C. and Olsson, C.AEditors: Buchsbaum., H.J. and Schmidt, J.D..W.B. Saunders Comp., PhiladelphiaEdition 3rd,1992
• Advances in Urology 
  Chapter: Flow Cytometry in Urologic Practice 
  Page 11 - 32Benson, M.C. and Whang, I.SEditors: Lytton, B., Catalona, W.J., Lipshultz, L.I. and McGuire, E.J..Mosby-Year Book, Inc., Chicago1992
• Controversies in the Management of Prostate Cancer 
  Chapter: Flow Cytometric Assessment of Prostate Cancer 
  Benson, M.CEditors: Wein, A.J. and Malkowicz, S.B..CoMed Communications, Philadelphia1992
• High Tech Urology 
  Chapter: Flow Cytometry in Urology 
  Page 234 - 250Whang, I.S. and Benson, M.CEditors: Smith, J.A. Jr..W.B. Saunders Comp, Philadelphia1992
• Campbell's Urology 
  Chapter: Urinary Diversion 
  Page 2654 - 2720Benson, M.C. and Olsson, C.AEditors: Walsh, P.C., Retik, A.B., Stamey, T.A. and Vaughan, E.D..W.B. Saunders, Philadelphia1992
• Current Therapy in Genitourinary Surgery 
  Chapter: Pheochromocytoma 
  Page 4 - 9Walton, G., Whang, I.S. and Benson, M.CEditors: Resnick, M.I. and Kursh, E.D..B.C. Decker, St. Louis1992
• Surgical Management of Urologic Disease 
  Chapter: Surgery for Prostate Cancer 
  Page 667 - 676Ring, K., Olsson, C.A. and Benson, M.CEditors: Droller, M.Mosby-Year Book, Inc, Chicago1992
• The Prostate 
  Chapter: The Staging and Grading of Prostatic Cancer 
  Page 261 - 272Benson, M.C. and Olsson, C.AEditors: Fitzpatrick, J.M. and Krane, R.Churchill Livingstone, London1989
• Join now to see all

Lectures

• Necessity of Confirmatory Prostate Biopsy to Insure Accurate Eligibility for Active Surveillance 
  Atlanta, Georgia - 1/1/2012
• Lessons Learned from Routine Intraoperative Ureteral Margin Frozen Sections over Five Years 
  Atlanta, Georgia - 1/1/2012
• Routine Transition Zone Biopsy during Active Surveillance for Prostate Cancer Rarely Provides Unique Evidence of Disease Progression 
  Atlanta, Georgia - 1/1/2012
• Intermittent vs. Continuous Androgen Deprivation Therapy among Elderly Patients with Advanced Prostate Cancer 
  Atlanta, Georgia - 1/1/2012
• Long-term Outcomes of Distal Ureteral Reconstruction with Reimplantation for Benign or Malignant Ureteral Obstruction or Injury 
  Atlanta, Georgia - 1/1/2012
• Updated Results of the Combined Phase I/ii Trial of Intravesical Nanoparticle Albumin-bound Paclitaxel in the Treatment of BCG Refractory Non-muscle Invasive Transitio... 
  Atlanta, Georgia - 1/1/2012
• Long-term Survival Outcomes with Intravesical Docetaxel in the Management of Non-muscle-invasive Bladder Cancer (NMIBC) Refractory to Bcg Therapy 
  Atlanta, Georgia - 1/1/2012
• Patterns of Care in the Use of Palliative Therapy for Ureteral Obstruction among Elderly Patients with Advanced Prostate Cancer 
  Atlanta, Georgia - 1/1/2012
• Does the Time Interval from Transrectal Ultrasound Guided Biopsy to Radical Prostatectomy Influence Margin Status? 
  Atlanta, Georgia - 1/1/2012
• Impact of Minimally Invasive Surgery on Contemporary Open Prostatectomy 
  Atlanta, Georgia - 1/1/2012
• Predictors of Adverse Pathological Features at Radical Prostatectomy for Patients Qualifying for Active Surveillance 
  Atlanta, Georgia - 1/1/2012
• The Pathologic and Clinical Outcomes of Men with Low-risk Microfocal Prostate Cancer 
  Atlanta, Georgia - 1/1/2012
• Safety of the Antimyostatin Monoclonal Antibody LY2495655 in Healthy Subjects and Patients with Advanced Cancer 
  Chicago, Illinois - 1/1/2012
• Xenotropic Murine Leukemia Virus Related Virus (XMRV) Is Present in Malignant Prostate Tissue but Does Not Pathological or Clinical Outcome 
  Washington, D.C - 1/1/2011
• Does Lymph Node Invasion Impact Biochemical Recurrence Free Survival (BCRFS) Following Radical Prostatectomy in Men with Seminal Vesicle Invasion? 
  Washington, D.C - 1/1/2011
• Immediate Radical Cystectomy versus Conservative Management of High Grade CT1N0M0 Bladder Cancer: Is There a Survival Difference? 
  Washington, D.C - 1/1/2011
• Phase I Trial of Intravesical Nanoparticle Albumin-bound Paclitaxel in the Treatment of BCG-refractory Non-muscle-invasive Bladder Cancer 
  Chicago, Illinois - 1/1/2010
• Systemic Chemotherapy Regimen Influences Outcome in Advanced Bladder Cancer 
  San Francisco, California - 1/1/2010
• Systemic Chemotherapy Regimen for Bladder Cancer Influences Outcome in Neoadjuvant and Adjuvant Settings 
  San Francisco, California - 1/1/2010
• Statin Drugs, Prostate Specific Antigen and Biochemical Outcome following Radical Prostatectomy 
  San Francisco, California - 1/1/2010
• The Correlation between Number of Lymph Nodes Removed during Radical Prostatectomy and Surgical Margin Status 
  San Francisco, California - 1/1/2010
• Tumor Diameter Independently Predicts Preoperative Estimated Glomerular Filtration Rate in Patients with Renal Cell Carcinoma 
  San Francisco, California - 1/1/2010
• Carboplatin Vs Cisplatin-based Chemotherapy in the Perioperative Treatment of Muscle-invasive Bladder Cancer 
  San Francisco, California - 1/1/2010
• Does the Presence of Muscularis Propria on Biopsy Affect the Rate of Upstaging in T1 Bladder Cancer 
  San Francisco, California - 1/1/2010
• The Role of Taxanes in BCG Resistant Non-Muscle Invasive Transitional Cell Cancer of the Bladder 
  Stockholm, Sweden - 1/1/2009
• Join now to see all

Other

• Prostatectomy 
  Benson, M.C., Columbia University College of Physicians and Surgeons Guide to Surgery
  http://ci.columbia.edu/surgery
  1/1/2002
• Pheochromocytoma 
  Kang, Y. and Benson, M.C, AUA Patient Education Web Project
  1/1/2002
• Primary Hyperaldosteronism – Conn’s Syndrome 
  Kang, Y. and Benson, M.C, AUA Patient Education Web Project
  1/1/2002